[1]
|
N. Abraham and D. H. Kwon, “A Single Amino Acid Substitution in PmrB Is Associated with Polymyxin B Resistance in Clinical Isolate of Pseudomonas aeruginosa,” FEMS Microbiology Letters, Vol. 298, No. 2, 2009, pp. 249-254.
doi:10.1111/j.1574-6968.2009.01720.x
|
[2]
|
J. A. Driscoll, S. L. Brody and M. H. Kollef, “The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections,” Drugs, Vol. 67, No. 3, 2007, pp. 351-368. doi:10.2165/00003495-200767030-00003
|
[3]
|
T. P. Lodise, C. D. Miller, J. Graves, J. P. Furuno, J. C. McGregor, B. Lomaestro, et al., “Clinical Prediction Tool to Identify Patients with Pseudomonas aeruginosa Respiratory Tract Infections at Greatest Risk for Multidrug Resistance,” Antimicrobial Agents and Chemotherapy, Vol. 51, No. 2, 2007, pp. 417-422. doi:10.1128/AAC.00851-06
|
[4]
|
C. S. McVay, M. Velasquez and J. A. Fralick, “Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model,” Antimicrobial Agents and Chemotherapy, Vol. 51, No. 6, 2007, pp. 1934-1938.
doi:10.1128/AAC.01028-06
|
[5]
|
R. Mittal, R. K. Khandwaha, V. Gupta, P. K. Mittal and K. Harjai, “Phenotypic Characters of Urinary Isolates of Pseudomonas aeruginosa & Their Association with Mouse Renal Colonization,” The Indian Journal of Medical Research, Vol. 123, No. 1, 2006, pp. 67-72.
|
[6]
|
J. Li, R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard and C. R. Rayner, et al., “Colistin: The Re-Emerging Antibiotic for Multidrug-Resistant Gram-Negative Bacterial Infections,” The Lancet Infectious Diseases, Vol. 6, No. 9, 2006, pp. 589-601. doi:10.1016/S1473-3099(06)70580-1
|
[7]
|
T. M. Arnold, G. N. Forres and K. J. Messmer, “Polymyxin Antibiotics for Gram-Negative Infections,” American Journal of Health-System Pharmacy, Vol. 64, No. 8, 2007, pp. 819-826. doi:10.2146/ajhp060473
|
[8]
|
M. E. Falagas, P. I. Rafailidis, D. K. Matthaiou, S. Virtzili, D. Nikita and A. Michalopoulos, “Pandrug-Resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii Infections: Characteristics and Outcome in a Series of 28 Patients,” International Journal of Antimicrobial Agents, Vol. 32, No. 5, 2008, pp. 450-454.
doi:10.1016/j.ijantimicag.2008.05.016
|
[9]
|
C. Y. Wang, J. S. Jerng, K. Y. Chen, L. N. Lee, C. J. Yu, P. R. Hsueh, et al., “Pandrug-Resistant Pseudomonas aeruginosa among Hospitalised Patients: Clinical Features, Risk-Factors and Outcomes,” Clinical Microbiology and Infection, Vol. 12, No. 1, 2006, pp. 63-68.
doi:10.1111/j.1469-0691.2005.01305.x
|
[10]
|
M. E. Falagas and I. A. Bliziotis, “Pandrug-Resistant Gram-Negative Bacteria: The Dawn of the Post-Antibiotic Era?” International Journal of Antimicrobial Agents, Vol. 29, No. 6, 2007, pp. 630-636.
doi:10.1016/j.ijantimicag.2006.12.012
|
[11]
|
D. Landman, S. Bratu, M. Alam and J. Quale, “Citywide Emergence of Pseudomonas aeruginosa Strains with Reduced Susceptibility to Polymyxin B,” Journal of Antimicrobial Chemotherapy, Vol. 55, No. 6, 2005, pp. 954- 957. doi:10.1093/jac/dki153
|
[12]
|
S. Gupta, D. Govil, P. N. Kakar, O. Prakash, D. Arora, S. Das, et al., “Colistin and Polymyxin B: A Re-Emergence,” Indian Journal of Critical Care Medicine, Vol. 13, No. 2, 2009, pp. 49-53. doi:10.4103/0972-5229.56048
|
[13]
|
A. P. Zavascki, L. Z. Goldani, J. Li and R. L. Nation, “Polymyxin B for the Treatment of Multidrug-Resistant Pathogens: A Critical Review,” Journal of Antimicrobial Chemotherapy, Vol. 60, No. 6, 2007, pp. 1206-1215.
doi:10.1093/jac/dkm357
|
[14]
|
M. R. Yeaman and N. Y. Yount, “Mechanisms of Antimicrobial Peptide Action and Resistance,” Pharmacological Reviews, Vol. 55, No. 1, 2003, pp. 27-55.
doi:10.1124/pr.55.1.2
|
[15]
|
E. L. Macfarlane, A. Kwasnicka and R. E. Hancock, “Role of Pseudomonas aeruginosa PhoP-PhoQ in Resis- tance to Antimicrobial Cationic Peptides and Aminoglycosides,” Microbiology, Vol. 146, No. 10, 2000, pp. 2543- 2554.
|
[16]
|
E. L. Macfarlane, A. Kwasnicka, M. M. Ochs and R. E. Hancock, “PhoP-PhoQ Homologues in Pseudomonas aeruginosa Regulate Expression of the Outer-Membrane Protein OprH and Polymyxin B Resistance,” Molecular Microbiology, Vol. 34, No. 2, 1999, pp. 305-316.
doi:10.1046/j.1365-2958.1999.01600.x
|
[17]
|
J. B. McPhee, M. Bains, G. Winsor, S. Lewenza, A. Kwasnicka, M. D. Brazas, et al., “Contribution of the PhoP-PhoQ and PmrA-PmrB Two-Component Regulatory Systems to Mg2+-Induced Gene Regulation in Pseudomonas aeruginosa,” Journal of Bacteriology, Vol. 188, No. 11, 2006, pp. 3995-4006. doi:10.1128/JB.00053-06
|
[18]
|
J. B. McPhee, S. Lewenza and R. E. Hancock, “Cationic Antimicrobial Peptides Activate a Two-Component Regulatory System, PmrA-PmrB, That Regulates Resistance to Polymyxin B and Cationic Antimicrobial Peptides in Pseudomonas aeruginosa,” Molecular Microbiology, Vol. 50, No. 1, 2003, pp. 205-217.
doi:10.1046/j.1365-2958.2003.03673.x
|
[19]
|
K. Barrow and D. H. Kwon, “Alterations in Two-Component Regulatory Systems of phoPQ and pmrAB Are Associated with Polymyxin B Resistance in Clinical Isolates of Pseudomonas aeruginosa,” Antimicrobial Agents and Chemotherapy, Vol. 53, No. 12, 2009, pp. 5150-5154.
doi:10.1128/AAC.00893-09
|
[20]
|
S. M. Moskowitz, R. K. Ernst and S. I. Miller, “pmrAB, a Two-Component Regulatory System of Pseudomonas aeruginosa That Modulates Resistance to Cationic Antimicrobial Peptides and Addition of Aminoarabinose to Lipid A,” Journal of Bacteriology, Vol. 186, No. 2, 2004, pp. 575-579.
|
[21]
|
S. M. Park, C. D. Lu and A. T. Abdelal, “Cloning and Characterization of argR, a Gene That Participates in Regulation of Arginine Biosynthesis and Catabolism in Pseudomonas aeruginosa PAO1,” Journal of Bacteriology, Vol. 179, No. 17, 1997, pp. 5300-5308.
|
[22]
|
S. Stibitz, W. Black and S. Falkow, “The Construction of a Cloning Vector Designed for Gene Replacement in Bordetella pertussis,” Gene, Vol. 50, No. 1-3, 1986, pp. 133- 140. doi:10.1016/0378-1119(86)90318-5
|
[23]
|
M. J. Gambello and B. H. Iglewski, “Cloning and Characterization of the Pseudomonas aeruginosa lasR Gene, a Transcriptional Activator of Elastase Expression,” Journal of Bacteriology, Vol. 173, No. 9, 1991, pp. 3000-3009.
|
[24]
|
C. A. Trieber and D. E. Taylor, “Mutations in the 16S rRNA Genes of Helicobacter pylori Mediate Resistance to Tetracycline,” Journal of Bacteriology, Vol. 184, No. 8, 2002, pp. 2131-2140.
doi:10.1128/JB.184.8.2131-2140.2002
|
[25]
|
D. H. Kwon and C. D. Lu, “Polyamines Induce Resis- tance to Cationic Peptide, Aminoglycoside, and Quinolone Antibiotics in Pseudomonas aeruginosa PAO1,” Antimicrobial Agents and Chemotherapy, Vol. 50, No. 5, 2006, pp. 1615-1622. doi:10.1128/AAC.50.5.1615-1622.2006
|